THE ENIGMA OF HLA-MEDIATED ADVERSE DRUG REACTIONS: EPOXIDE BUT NOT CARBAMAZEPINE INDUCES THE BINDING OF HAPTENATED PEPTIDES TO HLA-B*15:02

被引：0
作者：
Simper, Gwendolin S. [1 ]
Celik, Alexander A. [1 ]
Ho, Gia-Gia T. [1 ]
Huyton, Trevor [2 ]
Kuhn, Joachim [3 ]
Blasczyk, Rainer [1 ]
Bade-Doeding, Christina [1 ]
机构：
[1] Hannover Med Sch, Hannover, Germany
[2] Max Planck Inst, Gottingen, Germany
[3] Heart & Diabet Ctr North Rhine Westphalia, Bad Oeynhausen, Germany
来源：
HLA | 2018年 / 91卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
O1
引用
收藏
页码：322 / 322
页数：1
相关论文
共 50 条
[41]   Association between HLA-B*46:01 and cutaneous adverse drug reactions in Han Chinese [J].
Jiang MengLin ;
Wang LanTing ;
Chen ShengAn ;
Yang FanPing ;
Xiong Hao ;
Su Yu ;
Zhu HuiZhong ;
Qi Zheng ;
Qin ShengYing ;
Luo XiaoQun ;
Xing QingHe .
生物组学研究杂志（英文）, 2018, 1 (02) :73-78
[42]   HLA-A*31:01 and HLA-B*15:02 association with Stevens-Johnson syndrome and toxic epidermal necrolysis to carbamazepine in a multiethnic Malaysian population [J].
Khor, Amy Hui-Ping ;
Lim, Kheng-Seang ;
Tan, Chong-Tin ;
Kwan, Zhenli ;
Tan, Wooi-Chiang ;
Wu, David Bin-Chia ;
Ng, Ching-Ching .
PHARMACOGENETICS AND GENOMICS, 2017, 27 (07) :275-278
[43]   Association of the HLA-B*15:02 allele with pure cervical lymphadenopathy induced by carbamazepine and oxcarbazepine: A case report and literature review [J].
Liu, Hailing ;
Lan, Song ;
Liu, Detian ;
Xu, Meng ;
Yi, Yonghong ;
Li, Bingmei ;
Liu, Xiaorong .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 128 (02) :348-351
[44]   The role of HLA B*13:01 and HLA B*15:02 for predicting sulfonamide/trimethoprim-induced Severe Cutaneous Adverse Reactions (SCARs) [J].
Pinyopornpanish, Kanokkarn ;
Laisuan, Wannada .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) :AB114-AB114
[45]   Association between HLA-B*15:02 and oxcarbazepine-induced cutaneous adverse reaction: a meta-analysis [J].
Liu, Yiwei ;
Yu, Yuncui ;
Nie, Xiaolu ;
Zhao, Libo ;
Wang, Xiaoling .
PHARMACOGENOMICS, 2018, 19 (06) :547-552
[46]   Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study [J].
Van den Driessche, George ;
Fourches, Denis .
JOURNAL OF CHEMINFORMATICS, 2017, 9
[47]   HLA-B*51: 01 is strongly associated with clindamycin-related cutaneous adverse drug reactions [J].
Yang, Y. ;
Chen, S. ;
Yang, F. ;
Zhang, L. ;
Alterovitz, G. ;
Zhu, H. ;
Xuan, J. ;
Yang, X. ;
Luo, H. ;
Mu, J. ;
He, L. ;
Luo, X. ;
Xing, Q. .
PHARMACOGENOMICS JOURNAL, 2017, 17 (06) :501-505
[48]   Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study [J].
George Van Den Driessche ;
Denis Fourches .
Journal of Cheminformatics, 9
[49]   HLA-B Alleles and Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Han Chinese Population [J].
Shi, Yi-Wu ;
Min, Fu-Li ;
Liu, Xiao-Rong ;
Zan, Li-Xuan ;
Gao, Mei-Mei ;
Yu, Mei-Juan ;
Liao, Wei-Ping .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 (01) :42-46
[50]   HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions [J].
Y Yang ;
S Chen ;
F Yang ;
L Zhang ;
G Alterovitz ;
H Zhu ;
J Xuan ;
X Yang ;
H Luo ;
J Mu ;
L He ;
X Luo ;
Q Xing .
The Pharmacogenomics Journal, 2017, 17 :501-505
12345